Clinical and genomic predictors of sipuleucel-T outcomes in men with metastatic androgen pathway modulator resistant prostate cancer
- DOI
- 10.21203/rs.3.rs-10042173/v1
- Published
- 2026-07-01
- Container
- Not recorded
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 60/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- cautionPublication version: Identified as a preprint; peer review and later versions may change the record.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.21203/rs.3.rs-10042173/v1,
title = {Clinical and genomic predictors of sipuleucel-T outcomes in men with metastatic androgen pathway modulator resistant prostate cancer},
author = {Andrew Armstrong and Tara Seibert and Jane McKenzie and Lauren Howard and Bilal Ashraf and Jasmine Lu and Kallie White and Daniel George and Jeffrey Shevach and Joseph Park and Dillon Cockrell and Kristen Davis and Michael Harrison and Christopher Hoimes and Jordan Infield and Matthew Labriola and Hannah McManus and Sundhar Ramalingam},
year = {2026},
doi = {10.21203/rs.3.rs-10042173/v1},
url = {https://doi.org/10.21203/rs.3.rs-10042173/v1}
}RIS
TY - JOUR TI - Clinical and genomic predictors of sipuleucel-T outcomes in men with metastatic androgen pathway modulator resistant prostate cancer AU - Andrew Armstrong AU - Tara Seibert AU - Jane McKenzie AU - Lauren Howard AU - Bilal Ashraf AU - Jasmine Lu AU - Kallie White AU - Daniel George AU - Jeffrey Shevach AU - Joseph Park AU - Dillon Cockrell AU - Kristen Davis AU - Michael Harrison AU - Christopher Hoimes AU - Jordan Infield AU - Matthew Labriola AU - Hannah McManus AU - Sundhar Ramalingam PY - 2026 DO - 10.21203/rs.3.rs-10042173/v1 UR - https://doi.org/10.21203/rs.3.rs-10042173/v1 ER -
APA
Armstrong, A., Seibert, T., McKenzie, J., Howard, L., Ashraf, B., Lu, J., White, K., George, D., Shevach, J., Park, J., Cockrell, D., Davis, K., Harrison, M., Hoimes, C., Infield, J., Labriola, M., McManus, H., & Ramalingam, S. (2026). Clinical and genomic predictors of sipuleucel-T outcomes in men with metastatic androgen pathway modulator resistant prostate cancer. https://doi.org/10.21203/rs.3.rs-10042173/v1
Source records
- crossref · retrieved 2026-11-10T14:49:41.641Z